21 Oct 2021 --- Increased consumer demand for immunity products ahead of the winter season is a key driver behind BioGaia’s growth, according to the Sweden-based company. It has announced a 32% increase in net sales for the third quarter, reaching SEK 173.8 million (US$20.2 million), excluding foreign exchange effects.
